Portfolio map · Growth fund · United States

RTW Investments LLC portfolio map

69 startups RTW Investments LLC has backed in rounds we track, since 2017, grouped by their main sector. Together they have raised $14B; RTW Investments LLC led at least one round in 2 of them. The biggest sector is Biotech, with 52 companies.

69startups backed
3sectors
$14Braised between them
Biotechbiggest sector

RTW Investments LLC's investor profile

Segment by segment

Biotech

52 startups · $11B raised

  1. Oruka TherapeuticsOruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.United States$880M
  2. Spyre TherapeuticsSpyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.United States$678M
  3. Kailera TherapeuticsKailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.United States$600M
  4. Immunic TherapeuticsImmunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.United States$400M
  5. Century TherapeuticsCentury Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.United States$385M
  6. Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
  7. Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
  8. Belite BioBelite Bio is a clinical stage biopharmaceutical drug development company.United States$350M

Pharma

14 startups · $3.3B raised

  1. Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.United States$788M
  2. Dianthus TherapeuticsDianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.United States$719M
  3. ACELYRINACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.United States$300M
  4. Cullinan TherapeuticsCullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.United States$280M
  5. GH ResearchGH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.Ireland$268M
  6. Jade BiosciencesJade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.United States$195M
  7. OcugenOcugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.United States$151M
  8. Artios PharmaArtios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.United Kingdom$148M

Healthtech

3 startups · $279M raised

  1. Oricell TherapeuticsOricell Therapeutics is a clinical-stage biotechnology company based in Shanghai, China, founded in 2015.China$180M
  2. Magnolia Medical TechnologiesMagnolia Medical Technologies is a Seattle-based healthcare company focused on improving diagnostic accuracy for sepsis detection United States$69M
  3. LENZ TherapeuticsLENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.United States$30M

How this map is made. Every startup here has raised money in a round we track that names RTW Investments LLC as an investor, the first in 2017. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like RTW Investments LLC?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.